Acquired genetic alteration IVDs
Nchi: Australia
Lugha: Kiingereza
Chanzo: Department of Health (Therapeutic Goods Administration)
Ripoti ya Tathmini ya umma
(PAR)
08-11-2017
Hati zingine za bidhaa hii hazipatikani kwa sasa, unaweza kutuma ombi kwa huduma ya wateja wetu na tutakuarifu mara tu tutakapopata.
Tuma ombi.
Tuma ombi.
Inapatikana kutoka:
Sysmex Australia Pty Ltd
Darasa:
Class 3
Viwandani na:
Cytocell Ltd 418 Cambridge Science Park Milton Road, Oxford Gene Technology, Cambridge, CB4 0PZ United Kingdom
Eneo la matibabu:
CT929 - Acquired genetic alteration IVDs
Matibabu dalili:
IVDs that are intended to be used in genetic testing to provide information about acquired genetic alterations, which may include chromosomal alterations, mutations and/or alterations in gene expression, and which may be used to characterise haematological or solid tumour malignancies and/or provide prognostic information. These products are intended for use as an adjunct to classic cytogenetics and not as independent tests or assays.
Idhini hali ya:
A
Idhini ya tarehe:
2014-07-21
